UiPath (PATH) Stock Analysis & Winston Score

UiPath makes software that teaches computers to do repetitive tasks that humans normally handle, like filling out forms, copying data between systems, or processing invoices. This is called robotic process automation, or RPA. Large companies in banking, healthcare, insurance, and government are the main customers, and UiPath is one of the largest RPA software vendors in the world.

The company earns money primarily through software subscriptions and licenses, with customers paying annually to use its automation platform. UiPath operates globally, with significant revenue from North America and Europe, and generates strong gross margins above 80%, which reflects the high-margin nature of software. The main growth driver is expanding its platform beyond basic automation into AI-powered tools that can handle more complex tasks, but the main risk is intense competition from larger software companies like Microsoft and ServiceNow, which are building similar automation features directly into products many businesses already use.

Winston Score History

Politician Trades

1 trades / 12mo

0 Congressional buys and 1 sell on PATH in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+13.6% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+111.1% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$385M/ year

→ Flat (+1% vs prior year)

23.9% of revenue

1.6x the sector average (15%)

Steady R&D investment year-over-year

Insider Activity

22.9%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$871M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

UiPath is a rare growth stock that's already generating positive cash flow while growing at 14%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+0.7% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 541.2M (2022) → 544.9M (2026)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

84.9%

Premium pricing power — 84.9% gross margin

Operating Margin

16.7%

Healthy — 16.7% operating margin

ROCE

3.9%

Weak — 3.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+17.1%

Fast-growing sales (17.1% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

8/8 quarters

Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

112%

Turns 112% of profit into real cash

FCF Margin

22.9%

Converts sales into free cash efficiently (22.9%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

100.00x

—

Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

18.6x

Fair value — P/E 18.6

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward

+5.0

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (18.6 → 13.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial